(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PHARMA DAYS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PHARMA DAYS

ST13

US500000077969406

Class

35

Filing

77969406

Registration

3971623

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

09/27/2021

Trademark type

Word

Nice classes

35

Filing date

03/26/2010

Registration date

05/31/2011

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/27/2021

Last transaction

09/27/2021

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/05/2008

First use in commerce

11/05/2008

Drawing code

4

Owner type

03

Owner location

Cambridge, MA, US

Examiner

SCHRODY, ALLISON PAIGE

Law office

M60

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Massachusetts Biotechnology Council, Inc.

Representatives

Jessica L. Rothstein GOODWIN PROCTER LLP

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

BUSINESS CONSULTING SERVICESCONNECTING BIOTECHNOLOGY COMPANIES WITH PHARMACEUTICAL COMPANIESASSISTING BIOTECHNOLOGY COMPANIES IN FORMING POTENTIAL PARTNERSHIPSPROVIDING NETWORKING OPPORTUNITIES WITHIN A COMMUNITY OF BUSINESS DEVELOPMENT PROFESSIONALS

Publications

History of USPTO decisions and trademark events.

35 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/27/2021

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

09/27/2021

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/27/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/27/2021

E89R

TEAS SECTION 8 & 9 RECEIVED

05/21/2021

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/31/2020

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

07/18/2017

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

07/18/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/18/2017

E815

TEAS SECTION 8 & 15 RECEIVED

05/25/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/19/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

05/31/2011

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

04/28/2011

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

04/27/2011

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

04/26/2011

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/05/2011

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/31/2011

IUAF

USE AMENDMENT FILED

03/24/2011

EISU

TEAS STATEMENT OF USE RECEIVED

03/24/2011

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/26/2010

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/31/2010

PUBO

PUBLISHED FOR OPPOSITION

08/31/2010

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/24/2010

ALIE

ASSIGNED TO LIE

07/24/2010

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/08/2010

XAEC

EXAMINER'S AMENDMENT ENTERED

07/08/2010

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/08/2010

GNEA

EXAMINERS AMENDMENT E-MAILED

07/08/2010

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/08/2010

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/29/2010

GNRT

NON-FINAL ACTION E-MAILED

06/29/2010

CNRT

NON-FINAL ACTION WRITTEN

06/29/2010

DOCK

ASSIGNED TO EXAMINER

06/26/2010

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/31/2010

NWAP

NEW APPLICATION ENTERED

03/30/2010

Continuous trademark protection

Get notified about every new filing that threatens PHARMA DAYS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.